Innovative Product OfferingsMia Femtech features no general anesthesia and no significant downtime while increasing breast cups 1-2 sizes, expanding the market appeal beyond the traditional breast augmentation crowd.
Product Launch And Market ExpansionThe rollout of Preservé plays a key role in ESTA's minimally invasive strategy for the US market.
Strong Financial PerformanceRevenue growth improved to 16% from 11%, and US sales grew approximately 70% sequentially, beating consensus.